NCT03521180View on ClinicalTrials.gov

A Study to Evaluate Gluten Challenge on Immune Responses in Subjects With Celiac Disease

CompletedOBSERVATIONAL
Enrollment

5

Participants

Timeline

Start Date

May 11, 2018

Primary Completion Date

July 18, 2019

Study Completion Date

July 18, 2019

Conditions
Celiac Disease
Trial Locations (2)

75247

Covance, Dallas

98101

Virginia Mason Medical Center, Seattle

Sponsors

Lead Sponsor

Celgene
All Listed Sponsors
lead

Celgene

INDUSTRY

NCT03521180 - A Study to Evaluate Gluten Challenge on Immune Responses in Subjects With Celiac Disease | Biotech Hunter | Biotech Hunter